EAM
Exome Asset Management Portfolio holdings
AUM
$110M
This Quarter Return
+8.56%
1 Year Return
+24.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$110M
AUM Growth
+$110M
(-1.2%)
Cap. Flow
-$9.39M
Cap. Flow
% of AUM
-8.51%
Top 10 Holdings %
Top 10 Hldgs %
40.48%
Holding
78
New
17
Increased
8
Reduced
17
Closed
15
Top Buys
| 1 |
Tenet Healthcare
THC
|
$4.75M |
| 2 |
Verastem
VSTM
|
$2.49M |
| 3 |
Praxis Precision Medicines
PRAX
|
$2.48M |
| 4 |
WAY
Waystar Holding Corp
WAY
|
$1.92M |
| 5 |
10x Genomics
TXG
|
$1.9M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$4.73M |
| 2 |
Akero Therapeutics
AKRO
|
$3.09M |
| 3 |
Viridian Therapeutics
VRDN
|
$2.93M |
| 4 |
Savara
SVRA
|
$2.32M |
| 5 |
AnaptysBio
ANAB
|
$2.26M |
Sector Composition
| 1 | Healthcare | 97.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
BridgeBio Pharma
BBIO
$9.56B
| $6.72M | 4.99% |
155,533
-9,963
| -6% | -$430K |
|
2
Guardant Health
GH
$8.29B
| $5.11M | 3.8% |
98,182
-29,000
| -23% | -$1.51M |
|
3
Geron
GERN
$938M
| $4.81M | 3.58% |
3,414,377
+198,920
| +6% | +$280K |
|
4
Ionis Pharmaceuticals
IONS
$9.16B
| $4.79M | 3.56% |
121,116
-14,500
| -11% | -$573K |
|
|
5
Tenet Healthcare
THC
$16.4B
| $4.75M | 3.53% |
+27,000
| New | +$4.75M |
|
6
Cogent Biosciences
COGT
$1.68B
| $3.83M | 2.85% |
533,647
-88,031
| -14% | -$632K |
|
7
Cytokinetics
CYTK
$5.94B
| $3.83M | 2.85% |
115,817
+12,334
| +12% | +$408K |
|
8
Replimune Group
REPL
$461M
| $3.7M | 2.75% |
397,846
+103,000
| +35% | +$957K |
|
9
Eli Lilly
LLY
$659B
| $3.64M | 2.71% |
4,673
| – | – |
|
10
Soleno Therapeutics
SLNO
$3.57B
| $3.49M | 2.59% |
41,641
-1,800
| -4% | -$151K |
|
11
Intuitive Surgical
ISRG
$168B
| $3.46M | 2.57% |
6,358
| – | – |
|
12
Disc Medicine
IRON
$2.13B
| $3.25M | 2.42% |
61,356
-300
| -0.5% | -$15.9K |
|
13
Natera
NTRA
$23.2B
| $3.15M | 2.34% |
18,650
| – | – |
|
14
Fulcrum Therapeutics
FULC
$347M
| $3.06M | 2.28% |
444,949
-244,188
| -35% | -$1.68M |
|
15
Scholar Rock
SRRK
$3.18B
| $2.99M | 2.22% |
84,339
| – | – |
|
16
Syndax Pharmaceuticals
SNDX
$1.39B
| $2.89M | 2.15% |
308,298
-28,900
| -9% | -$271K |
|
|
17
Verastem
VSTM
$567M
| $2.49M | 1.85% |
+599,900
| New | +$2.49M |
|
|
18
Praxis Precision Medicines
PRAX
$946M
| $2.48M | 1.84% |
+59,002
| New | +$2.48M |
|
19
Penumbra
PEN
$10.5B
| $2.31M | 1.72% |
9,000
| – | – |
|
20
89bio
ETNB
$1.36B
| $2.29M | 1.7% |
233,426
-120,456
| -34% | -$1.18M |
|
21
Travere Therapeutics
TVTX
$1.62B
| $2.27M | 1.69% |
153,278
+35,261
| +30% | +$522K |
|
|
CNTA
22
Centessa Pharmaceuticals
CNTA
$2.32B
| $2.19M | 1.63% |
166,944
+24,200
| +17% | +$318K |
|
|
WAY
23
Waystar Holding Corp
WAY
$6.45B
| $1.92M | 1.43% |
+46,900
| New | +$1.92M |
|
24
Corbus Pharmaceuticals
CRBP
$119M
| $1.91M | 1.42% |
277,317
-12,373
| -4% | -$85.4K |
|
|
25
10x Genomics
TXG
$1.66B
| $1.9M | 1.41% |
+163,658
| New | +$1.9M |
|